Clinical Trial: Innovative Practical Research on Cutaneous Inflammatory Reactions in Tumor Patients Undergoing Immunotherapy Driven by the JBI Model (China)

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Innovative Practical Research on Cutaneous Inflammatory Reactions in Tumor Patients Undergoing Immunotherapy Driven by the JBI Model'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133647

Registration Time: 2026/09/30

Type: Interventional study

Primary Sponsor: Shanghai General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339923

Published by HT Digital Content Services with permission from Health Daily Digest....